whether Lantus increases cancer risk

Patients are asking whether Lantus increases cancer risk.

Recent European studies suggest a higher cancer risk in patients using Lantus (insulin glargine) ALONE compared to other insulins.

A Swedish study suggests one extra case of breast cancer for every 1000 women using Lantus alone for 1 year compared to other insulins.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote